- Report
- September 2026
- 182 Pages
Global
From €3566EUR$3,939USD£3,060GBP
- Report
- February 2026
- 250 Pages
Global
From €4065EUR$4,490USD£3,488GBP
- Report
- September 2026
- 225 Pages
Global
From €5296EUR$5,850USD£4,545GBP
- Report
- August 2026
- 100 Pages
Global
From €4300EUR$4,750USD£3,690GBP
The Specimen Validity Test (SVT) market is a segment of the In Vitro Diagnostics (IVD) industry. It is focused on the development and commercialization of tests that assess the integrity of biological samples used in laboratory testing. These tests are used to detect adulteration, substitution, and dilution of samples, which can lead to inaccurate results. SVT products are used in a variety of clinical settings, including drug testing, forensic toxicology, and clinical chemistry.
The SVT market is driven by the increasing demand for accurate and reliable laboratory testing results. This is due to the growing prevalence of chronic diseases, the need for accurate diagnosis, and the increasing use of laboratory testing in clinical settings. Additionally, the increasing adoption of point-of-care testing and the development of new technologies are expected to drive the growth of the SVT market.
Some of the major companies in the SVT market include Siemens Healthineers, Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, and Roche Diagnostics. Show Less Read more